Annual Long Term Debt
$146.90 K
-$67.20 K-31.39%
December 31, 2023
Summary
- As of February 12, 2025, ENTO annual long term debt is $146.90 thousand, with the most recent change of -$67.20 thousand (-31.39%) on December 31, 2023.
- During the last 3 years, ENTO annual long term debt has risen by +$127.80 thousand (+669.11%).
- ENTO annual long term debt is now -52.78% below its all-time high of $311.10 thousand, reached on December 1, 2021.
Performance
ENTO Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$80.20 K
-$20.80 K-20.59%
September 1, 2024
Summary
- As of February 12, 2025, ENTO quarterly long term debt is $80.20 thousand, with the most recent change of -$20.80 thousand (-20.59%) on September 1, 2024.
- Over the past year, ENTO quarterly long term debt has dropped by -$66.70 thousand (-45.41%).
- ENTO quarterly long term debt is now -98.77% below its all-time high of $6.53 million, reached on March 31, 2024.
Performance
ENTO Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
ENTO Long Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -31.4% | -45.4% |
3 y3 years | +669.1% | -59.2% |
5 y5 years | - | +145.3% |
ENTO Long Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -52.8% | at low | -98.8% | at low |
5 y | 5-year | -52.8% | -100.0% | -98.8% | -100.0% |
alltime | all time | -52.8% | -100.0% | -98.8% | -100.0% |
Entero Therapeutics Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $80.20 K(-20.6%) |
Jun 2024 | - | $101.00 K(-98.5%) |
Mar 2024 | - | $6.53 M(+4342.1%) |
Dec 2023 | $146.90 K(-31.4%) | $146.90 K(-11.5%) |
Sep 2023 | - | $166.00 K(-10.1%) |
Jun 2023 | - | $184.70 K(-6.0%) |
Mar 2023 | - | $196.50 K(-8.2%) |
Dec 2022 | $214.10 K | - |
Dec 2022 | - | $214.10 K(-7.4%) |
Sep 2022 | - | $231.30 K(-6.8%) |
Jun 2022 | - | $248.20 K(-6.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $264.50 K(-15.0%) |
Dec 2021 | $311.10 K(+1528.8%) | $311.10 K(+5.2%) |
Sep 2021 | - | $295.70 K(+3.5%) |
Jun 2021 | - | $285.80 K(+4230.3%) |
Mar 2021 | - | $6600.00(-65.4%) |
Dec 2020 | $19.10 K(>+9900.0%) | $19.10 K(-39.4%) |
Sep 2020 | - | $31.50 K(-27.8%) |
Jun 2020 | - | $43.60 K(>+9900.0%) |
Dec 2019 | $0.00 | $0.00(-100.0%) |
Sep 2019 | - | $32.70 K(-26.4%) |
Jun 2019 | - | $44.40 K |
FAQ
- What is Entero Therapeutics annual long term debt?
- What is the all time high annual long term debt for Entero Therapeutics?
- What is Entero Therapeutics annual long term debt year-on-year change?
- What is Entero Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Entero Therapeutics?
- What is Entero Therapeutics quarterly long term debt year-on-year change?
What is Entero Therapeutics annual long term debt?
The current annual long term debt of ENTO is $146.90 K
What is the all time high annual long term debt for Entero Therapeutics?
Entero Therapeutics all-time high annual long term debt is $311.10 K
What is Entero Therapeutics annual long term debt year-on-year change?
Over the past year, ENTO annual long term debt has changed by -$67.20 K (-31.39%)
What is Entero Therapeutics quarterly long term debt?
The current quarterly long term debt of ENTO is $80.20 K
What is the all time high quarterly long term debt for Entero Therapeutics?
Entero Therapeutics all-time high quarterly long term debt is $6.53 M
What is Entero Therapeutics quarterly long term debt year-on-year change?
Over the past year, ENTO quarterly long term debt has changed by -$66.70 K (-45.41%)